TY - JOUR
T1 - Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019
T2 - A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))
AU - Evers, Jelle
AU - Hendriks, Lizza E.L.
AU - De Jaeger, Katrien
AU - Wijsman, Robin
AU - De Ruysscher, Dirk
AU - Terhaard, Chris
AU - van der Sangen, Maurice
AU - Siesling, Sabine
AU - Struikmans, Henk
AU - Aarts, Mieke J.
N1 - Publisher Copyright:
© 2021 The Author(s)
PY - 2022/5
Y1 - 2022/5
N2 - The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Table 1 were included, whereas only the upper row regards ‘RT alone’ and the lower row regards ‘Chemotherapy alone’. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.
AB - The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Table 1 were included, whereas only the upper row regards ‘RT alone’ and the lower row regards ‘Chemotherapy alone’. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85121971376&partnerID=8YFLogxK
U2 - 10.1016/j.lungcan.2021.12.012
DO - 10.1016/j.lungcan.2021.12.012
M3 - Comment/Letter to the editor
C2 - 34973817
AN - SCOPUS:85121971376
SN - 0169-5002
VL - 167
SP - 107
JO - Lung Cancer
JF - Lung Cancer
ER -